Science
Science
Therapeutic Areas
Therapeutic Areas
Virology
Virology
HIV
Viral Hepatitis
COVID-19 and Emerging Viruses
Oncology
Inflammation
Pipeline
Research
Research
Our R&D Approach
Research Funding Programs
Research Funding Programs
Research Scholars Program
External-Sponsored Research
External-Sponsored Research
Virology RFP Opportunities
Oncology RFP Opportunities
Inflammation RFP Opportunities
Community-Based Participatory Research
Research Publications
Clinical Trials
Diversity in Clinical Trials
Medicines
Medicines
Patient Safety
Patient Safety
Anti-Counterfeiting
Consumer Product Safety
Report an Adverse Event
Medication Access
Medication Access
U.S. Patient Access
Managed Access
Authorized Distributors
Responsibility
Responsibility
ESG
ESG
ESG Performance
ESG Focus Areas
ESG Frameworks and Reporting
Sustainability
Sustainability
Sustainability Focus Areas
Health Equity
Giving@Gilead
Giving@Gilead
Corporate Giving
Corporate Giving
Strategic Initiatives
Strategic Initiatives
All4Liver
Asia Pacific Rainbow Grant
COMPASS Initiative
HepConnect
HIV Age Positively
RADIAN
Setting the P.A.C.E.- Prevention, Arts and Advocacy, Community, Education
Gilead Oncology Grant
Toward Health Equity for Black People Impacted by TNBC
TRANScend
Zeroing In: Ending the HIV Epidemic
How to Apply for Funding
How to Apply for Funding
Giving in Africa
Giving in Asia
Giving in Australia
Giving in Europe & the Middle East
Giving in Latin America & the Caribbean
Giving in North America
Terms & Conditions
FAQs
Gilead Foundation
Gilead Foundation
Creating Possible Fund
Building Community Donations
Global Health and Access
Global Health and Access
FOCUS
Access in Low- and Middle-Income Countries
Access in Low- and Middle-Income Countries
Access Strategy for Long-Acting PrEP
Invasive Fungal Infections
Access Partnerships
Inclusion and Diversity
Inclusion and Diversity
Employee Resource Groups
Employee Resource Groups
GAIN
Gileados
GLOBE
GVET
Pride Alliance
Women at Gilead
Medical Education
Stories
Company
Company
Leadership
View All Leaders
Daniel O’Day
Andrew Dickinson
Stacey Ma
Dietmar Berger, MD, PhD
Flavius Martin, MD
Jyoti Mehra
Johanna Mercier
Cindy Perettie
Deborah H. Telman
Board of Directors
View All Directors
Daniel O’Day
Jacqueline K. Barton, PhD
Jeffrey A. Bluestone, PhD
Sandra J. Horning, MD
Kelly A. Kramer
Ted W. Love, MD
Harish Manwani
Javier J. Rodriguez
Anthony Welters
Board Governance and Committees
Investing in the U.S.
Media
Ethics and Compliance
Policies and Procedures
Policies and Procedures
AI Principles
Disclosures
U.S. Public Policy Engagement
U.S. Public Policy Engagement
Political Contributions Archives
Supplier Information
Supplier Information
Supplier Enablement Resources: SAP Ariba
Supplier Inclusion
Annual Impact Reports
U.S. Locations
Careers
Careers
Life at Gilead
Life at Gilead
Inclusion and Diversity in Hiring
Opportunities
Opportunities
Early Career Opportunities
Early Career Opportunities
Gilead Internship Program
Postdoctoral fellowships
Global Workforce
Media
Investors
Search
Search
Hamber
Gilead Sciences Q2 earnings:
View
on Aug. 7 at 1:30 p.m. (PT)
News Releases
News Releases
Filters
×
Categories
x
Clear All
Years
x
Clear All
Reset
Apply Filter
Search
Some of the content on this page is not intended for users outside the U.S.
Sort By:
Most recent
Most relevant
No Results Found
Media Contacts
Public_Affairs@gilead.com
Company Statements
View all